APA

Schwab I. R., Friedlaender M., McCulley J., Lichtenstein S. J. & Moran C. T. (20030324). A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. : Ophthalmology.

Chicago

Schwab Ivan R, Friedlaender Mitchell, McCulley James, Lichtenstein Steven J and Moran C Thomas. 20030324. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. : Ophthalmology.

Harvard

Schwab I. R., Friedlaender M., McCulley J., Lichtenstein S. J. and Moran C. T. (20030324). A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. : Ophthalmology.

MLA

Schwab Ivan R, Friedlaender Mitchell, McCulley James, Lichtenstein Steven J and Moran C Thomas. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. : Ophthalmology. 20030324.